LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer. [electronic resource]
Producer: 20170425Description: 1621-1628 p. digitalISSN:- 1433-8726
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- adverse effects
- Brazil -- epidemiology
- Follow-Up Studies
- Gonadotropin-Releasing Hormone -- analogs & derivatives
- Humans
- Incidence
- Insulin Resistance
- Male
- Metabolic Syndrome -- chemically induced
- Middle Aged
- Orchiectomy -- adverse effects
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- metabolism
- Risk Factors
- Testosterone -- metabolism
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.